{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T09:48:39Z","timestamp":1777110519802,"version":"3.51.4"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/jom.0b013e3181e48ec8","type":"journal-article","created":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T03:35:25Z","timestamp":1277955325000},"page":"680-684","source":"Crossref","is-referenced-by-count":13,"title":["Association Between IL-1A Single Nucleotide Polymorphisms and Chronic Beryllium Disease and Beryllium Sensitization"],"prefix":"10.1097","volume":"52","author":[{"given":"Erin C.","family":"McCanlies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berran","family":"Yucesoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Mnatsakanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Slaven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie L.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine R.","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Kreiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainsley","family":"Weston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210209","first-page":"150","article-title":"The diagnosis of beryllium disease, with special reference to the patch test.","volume":"19","author":"Curtis","year":"1959","journal-title":"AMA Arch Ind Health"},{"key":"R2-3-20210209","first-page":"937","article-title":"The natural history of beryllium sensitization and chronic beryllium disease.","volume":"104S","author":"Newman","year":"1996","journal-title":"Environ Health Perspect"},{"key":"R3-3-20210209","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.1016\/S0012-3692(15)35482-9","article-title":"Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.","volume":"121","author":"Maier","year":"2002","journal-title":"Chest"},{"key":"R4-3-20210209","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.171.12.6910","article-title":"Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.","volume":"171","author":"Maier","year":"2003","journal-title":"J Immunol"},{"key":"R5-3-20210209","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajim.20045","article-title":"The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.","volume":"46","author":"McCanlies","year":"2004","journal-title":"Am J Ind Med"},{"key":"R6-3-20210209","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/ajrccm.165.6.2104002","article-title":"Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.","volume":"165","author":"Rossman","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-3-20210209","first-page":"226","article-title":"A genetic marker for chronic beryllium disease.","volume":"86","author":"Saltini","year":"1995","journal-title":"Med Lav"},{"key":"R8-3-20210209","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1183\/09031936.01.00106201","article-title":"Major histocompatibility locus genetic markers of beryllium sensitization and disease.","volume":"18","author":"Saltini","year":"2001","journal-title":"Eur Respir J"},{"key":"R9-3-20210209","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0300-483X(01)00410-3","article-title":"Beryllium sensitivity is linked to HLA-DP genotype.","volume":"165","author":"Wang","year":"2001","journal-title":"Toxicology"},{"key":"R10-3-20210209","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.163.3.1647","article-title":"Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.","volume":"163","author":"Wang","year":"1999","journal-title":"J Immunol"},{"key":"R11-3-20210209","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1098\/rsif.2007.1223","article-title":"Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.","volume":"5","author":"Snyder","year":"2008","journal-title":"J R Soc Interface"},{"key":"R12-3-20210209","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/aje\/kwg001","article-title":"HLA-DPB1 and chronic beryllium disease: a HuGE review.","volume":"157","author":"McCanlies","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R13-3-20210209","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"},{"key":"R14-3-20210209","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1165\/ajrcmb.25.3.4349","article-title":"IL-9 stimulates release of chemotactic factors from human bronchial epithelial cells.","volume":"25","author":"Little","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R15-3-20210209","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/019021402753462040","article-title":"Human bronchial epithelium expresses interleukin-9 receptors and releases neutrophil chemotactic factor.","volume":"28","author":"Tsukadaira","year":"2002","journal-title":"Exp Lung Res"},{"key":"R16-3-20210209","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gene.6363645","article-title":"Cytokine gene polymorphism in human disease: on-line databases.","volume":"1","author":"Bidwell","year":"1999","journal-title":"Genes Immun"},{"key":"R17-3-20210209","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s004200100237","article-title":"Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.","volume":"74","author":"Henneberger","year":"2001","journal-title":"Int Arch Occup Environ Health"},{"key":"R18-3-20210209","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q","article-title":"Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms\/m3.","volume":"30","author":"Kreiss","year":"1996","journal-title":"Am J Ind Med"},{"key":"R19-3-20210209","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/oem.54.8.605","article-title":"Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.","volume":"54","author":"Kreiss","year":"1997","journal-title":"Occup Environ Med"},{"key":"R20-3-20210209","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajim.20140","article-title":"Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.","volume":"47","author":"Schuler","year":"2005","journal-title":"Am J Ind Med"},{"key":"R21-3-20210209","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.86.13.5099","article-title":"Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.","volume":"86","author":"Weston","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"R22-3-20210209","first-page":"707","article-title":"Genetics.","author":"Russell","year":"1992"},{"key":"R23-3-20210209","first-page":"21","article-title":"Cytokine Molecular Biology. Practical Approach.","author":"di Giovine","year":"2000"},{"key":"R24-3-20210209","doi-asserted-by":"crossref","first-page":"D617","DOI":"10.1093\/nar\/gkj151","article-title":"SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes.","volume":"34(Database issue)","author":"Packer","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"R25-3-20210209","article-title":"SAS\/STAT User's Guide. Version 9.1.","year":"2009"},{"key":"R26-3-20210209","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1034\/j.1398-9995.2000.00127.x","article-title":"Immune mechanisms in interstitial lung diseases.","volume":"55","author":"Semenzato","year":"2000","journal-title":"Allergy"},{"key":"R27-3-20210209","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cytogfr.2008.11.006","article-title":"Cytokine and cytokine receptor gene polymorphisms and their functionality.","volume":"20","author":"Smith","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"R28-3-20210209","first-page":"1189","article-title":"Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation.","volume":"134","author":"Shikama","year":"1989","journal-title":"Am J Pathol"},{"key":"R29-3-20210209","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/cimm.1994.1206","article-title":"Interleukin-1 (IL-1) is an important cytokine in granulomatous alveolitis.","volume":"157","author":"Denis","year":"1994","journal-title":"Cell Immunol"},{"key":"R30-3-20210209","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm.165.2.2106004","article-title":"Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis.","volume":"165","author":"Hutyrova","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-3-20210209","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0198-8859(99)00050-6","article-title":"The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans.","volume":"60","author":"Rybicki","year":"1999","journal-title":"Hum Immunol"},{"key":"R32-3-20210209","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1378\/chest.104.1.47","article-title":"Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis.","volume":"104","author":"Kline","year":"1993","journal-title":"Chest"},{"key":"R33-3-20210209","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1165\/ajrcmb.10.5.8179912","article-title":"Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.","volume":"10","author":"Bost","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R34-3-20210209","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00109-004-0626-0","article-title":"Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.","volume":"83","author":"Gaede","year":"2005","journal-title":"J Mol Med"},{"key":"R35-3-20210209","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.4049\/jimmunol.179.6.4255","article-title":"TGF-beta 1 variants in chronic beryllium disease and sarcoidosis.","volume":"179","author":"Jonth","year":"2007","journal-title":"J Immunol"},{"key":"R36-3-20210209","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/1097-0274(200103)39:3<286::AID-AJIM1016>3.0.CO;2-7","article-title":"Polymorphisms of the IL-1 gene complex in coal miners with silicosis.","volume":"39","author":"Yucesoy","year":"2001","journal-title":"Am J Ind Med"},{"key":"R37-3-20210209","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/taap.2001.9124","article-title":"Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis.","volume":"172","author":"Yucesoy","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"issue":"Suppl 5","key":"R38-3-20210209","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1289\/ehp.96104s5969","article-title":"Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease.","volume":"104","author":"Tinkle","year":"1996","journal-title":"Environ Health Perspect"},{"key":"R39-3-20210209","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1074\/jbc.M008662200","article-title":"Recombinant human interleukins IL-1alpha, IL-1beta, IL-4, IL-6, and IL-7 show different and specific calcium-independent carbohydrate-binding properties.","volume":"276","author":"Cebo","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Journal of Occupational &amp; Environmental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JOM.0b013e3181e48ec8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:40:55Z","timestamp":1740210055000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043764-201007000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jom.0b013e3181e48ec8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.6947957.7140055","asserted-by":"object"}]},"ISSN":["1076-2752"],"issn-type":[{"value":"1076-2752","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}